Evidence map›Paper›PMID 31125623›Full record

ArticleBehavioural brain research2019

Antidepressant effects of C-Terminal domain of the heavy chain of tetanus toxin in a rat model of depression.

Bruk Getachew, Liliana Mendieta, Antonei B Csoka, José Aguilera, Yousef Tizabi

Abstract read
In one paragraph

Article in Behavioural brain research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Health and Disease:Research (Washington, D.C.) · 2023
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bruk GetachewDepartment of Pharmacology, Howard University College of Medicine, Washington, DC, USA.
Liliana MendietaLaboratorio de Neuroquímica, Facultad de Ciencias Químicas, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico.
Antonei B CsokaDepartment of Anatomy, Howard University College of Medicine, Washington, DC, USA.
José AguileraInstitut de Neurociències and Departament de Bioquímica i de Biologia Molecular, Facultat de Medicina, Universitat Autònoma de Barcelona (UAB) and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.
Yousef TizabiDepartment of Pharmacology, Howard University College of Medicine, Washington, DC, USA. Electronic address: ytizabi@howard.edu.

Funding

Advancing aging research through development of minority GerontologistsR25AG047843 · NIA · HOWARD UNIVERSITY · PI DUTTAROY, ATANU · 2014 to 2024
$3.3M
Novel Interventions in Alcohol Induced DepressionR03AA022479 · NIAAA · HOWARD UNIVERSITY · PI TIZABI, YOUSEF · 2014 to 2015
$149k
NIAAA NIH HHS R03 AA022479NIA NIH HHS R25 AG047843
6 · The paper itself

Abstract

The C-terminal domain of the heavy chain of tetanus toxin (Hc-TeTx) may be of therapeutic potential in motor impairments associated with Parkinson disease (PD). Since depression is a common co-morbid condition with PD, we undertook this study to determine whether Hc-TeTx might also show antidepressant-like properties and whether central brain-derived neurotrophic factor (BDNF) and/or tumor necrosis factor (TNF)-alpha are also affected by it. Adult male Wistar-Kyoto rats, a putative animal model of depression, were treated with various doses of Hc-TeTx (0, 20, 40 and 60 μg/kg, IM) and their performance in the open field locomotor activity (OFLA) as well as in the forced swim test (FST) was evaluated at 24 h, one week and two weeks after the single injection. A separate group of rats were injected with 60 μg/kg Hc-TeTx and sacrificed 24 h later for neurochemical evaluations. Hc-TeTx resulted in a dose-dependent decrease in immobility score after 24 h, whereas OFLA was not affected. Concomitant with the 24 h behavioral effects, the levels of hippocampal and frontal cortical BDNF were significantly increased, whereas the levels of TNF-alpha in both these areas were significantly decreased. The decrease in immobility scores following higher doses of Hc-TeTx were still evident after one week, but not 2 weeks of rest. These results indicate long lasting antidepressant effects of a single Hc-TeTx dose and suggest potential utility of Hc-TeTx in PD-depression co-morbidity.

Indexed as

AnimalsAntidepressive AgentsBrainCorpus StriatumDepressionDepressive DisorderDisease Models, AnimalHippocampusLocomotionMaleMotor ActivityNeuroprotective AgentsParkinson DiseasePeptide FragmentsRatsRats, Inbred WKYAntidepressive AgentsNeuroprotective AgentsPeptide FragmentsTetanus Toxintetanus toxin fragment CBDNFForced swim testFrontal cortexHelplessnessHippocampusParkinson’s diseaseTNF-alpha

Identifiers

PMID31125623
PMCPMC6556421

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.